AD-101(Addpharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAD-101(Addpharma)
Drug Alias NameRaloxifene oral formulationmicronized raloxifene formulationAD-101(Yuhan)AD101(Yuhan)AD-101 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulatorsLysine-specific histone demethylase 1 inhibitors
TargetsEstrogen receptorsLysine-specific histone demethylase 1
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAddpharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAddpharma Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A